Location History:
- Wüfrath, DE (2014)
- Wulfrath, DE (2014)
- Wülfrath, DE (2012 - 2015)
Company Filing History:
18 out of 721 
1 out of 192 
1 out of 54 
Years Active: 2012-2015
Title: A Closer Look at Barbara Albrecht-Küpper: Innovator in Medicinal Chemistry
Introduction
Barbara Albrecht-Küpper, based in Wülfrath, Germany, is a prominent figure in the field of medicinal chemistry with an impressive portfolio of 20 patents. Her work focuses primarily on developing novel therapeutic compounds, especially for treating cardiovascular and metabolic disorders.
Latest Patents
Among her latest innovations are two significant patents. The first is titled "2-alkoxy-substituted dicyanopyridines and their use," which explores new compounds and methods for treating and preventing diseases, particularly cardiovascular disorders. The second patent, "Substituted aryloxazoles and their use," also focuses on novel derivatives aimed at treating cardiovascular and metabolic diseases. Both patents demonstrate her commitment to advancing medical treatments through innovative chemical solutions.
Career Highlights
Barbara has had a distinguished career working with esteemed organizations such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. Her experience in these companies has significantly contributed to her expertise in patent law and the commercialization of innovations in pharmaceuticals.
Collaborations
Throughout her career, Barbara has collaborated with notable professionals in the field. Two of her esteemed coworkers include Peter Nell and Alexandros Vakalopoulos, with whom she has likely worked on various projects and patent applications, sharing insights and expertise in their respective areas of research.
Conclusion
Barbara Albrecht-Küpper stands out as a leading inventor in the field of medicinal chemistry. With her substantial contributions through patents and collaborative efforts, she continues to push the boundaries of innovation in the treatment of critical health conditions. Her work not only enhances our understanding of medicinal compounds but also opens new avenues for effective therapies, contributing to the betterment of global health.